Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Lukas Flatz

From: Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Contact corresponding author